Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimized antiviral therapy in chronic hepatitis B
ChiCTR-TRC-08000219Phase 4Completed
- Sponsor
- The First Affiliated Hospital of Wenzhou Medical University
- Start
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of adefovir dipivoxil and lamivudine in Chronic Hepatitis B (CHB) (3 arms), sponsored by The First Affiliated Hospital of Wenzhou Medical University. Primary endpoints: HBV-DNA, serum liver function and 3 more. Started Nov 2008; status: completed.
02
Drugs
adefovir dipivoxillamivudine
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR-TRC-08000219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-08000219.